IGO (IGO) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
8 Dec, 2025Executive summary
Reported a net loss of AUD 782 million for 1H25, mainly due to significant impairments at Kwinana (AUD 525 million) and exploration assets (AUD 115 million), and a $602 million share of net loss from TLEA.
Underlying net loss, excluding impairments, was AUD 85 million, reflecting weak lithium and nickel prices and lower operating results from Nova and Forrestania.
Greenbushes delivered strong production, hitting the top end of guidance, with robust margins despite weak lithium markets.
Nova and Forrestania faced operational challenges, with Nova approaching end-of-life and Forrestania entering care and maintenance after a seismic event.
Maintained a strong cash position with AUD 247 million and AUD 720 million in undrawn debt facilities.
Financial highlights
Revenue fell to AUD 284 million, down 35% year-over-year (1H24: AUD 438 million).
Net loss after tax: AUD 782 million (1H24: AUD 288 million profit); underlying net loss: AUD 85 million.
Underlying EBITDA dropped to negative AUD 82 million from AUD 515 million year-over-year.
Net cash from operating activities was negative AUD 7 million, down from AUD 568 million in 1H24.
No interim dividend declared for 1H25 due to underlying cash outflow.
Outlook and guidance
Greenbushes production expected at the top end of 1,350–1,550kt guidance, with costs and CapEx at the lower end.
Nova production tracking to the lower end of guidance, with costs at the upper end.
Kwinana lithium hydroxide FY25 production guided at 7,000–8,000t, with conversion costs of AUD 22,000–25,000/t; capex expected at the lower end of AUD 80–100 million.
No dividends expected from TLA in FY25 due to weak lithium market and capital needs.
FY25 exploration spend unchanged at AUD 50–60 million, with further reduction expected in FY26.
Latest events from IGO
- Net loss after tax narrowed to AUD 34.1 million, with improved Nova EBITDA and no dividend declared.IGO
H1 202619 Feb 2026 - AGM revealed major losses, board renewal, and a refocused strategy on battery materials.IGO
AGM 20253 Feb 2026 - Operational strength at Nova and Greenbushes drove higher EBITDA and strong cash flow.IGO
Q2 20263 Feb 2026 - Strong cash flow, safety gains, and resilient core asset performance in FY24.IGO
Q4 20242 Feb 2026 - Strong Greenbushes output and safety gains, but revenue and profit declined sharply.IGO
H2 202423 Jan 2026 - Lithium-led growth, disciplined returns, and net zero by 2035 drive the refreshed strategy.IGO
Strategy Day 202420 Jan 2026 - Lower prices drove a $2.9M EBITDA loss and 39% revenue drop despite strong Greenbushes output.IGO
Q1 202518 Jan 2026 - Strong cash flow, leadership renewal, and lithium growth amid operational and governance challenges.IGO
AGM 202416 Jan 2026 - EBITDA loss driven by Kwinana and Nova, but Greenbushes delivered strong results.IGO
Q2 20259 Jan 2026